Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reduced Nitric Oxide Synthase Involvement in Aigamo Duck Basilar Arterial Relaxation. | Animals (Basel) | 2023 | 37685004 | PubTator, text mining | PubMed |
| Latest advances in the regulatory genes of adipocyte thermogenesis. | Front Endocrinol (Lausanne) | 2023 | 37680891 | PubTator, text mining | PubMed |
| Region-specific sympatho-adrenergic regulation of specialized vasculature in bone homeostasis and regeneration. | iScience | 2023 | 37680481 | PubTator, text mining | PubMed |
| Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles. | Front Mol Biosci | 2023 | 37664183 | PubTator, text mining | PubMed |
| The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity. | Open Med (Wars) | 2023 | 37663229 | PubTator, text mining | PubMed |
| Adrenergic Reprogramming of Preexisting Adipogenic Trajectories Steer Naïve Mural Cells Toward Beige Differentiation. | bioRxiv | 2023 | 37662295 | PubTator, text mining | PubMed |
| Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men. | EBioMedicine | 2023 | 37659283 | PubTator, text mining | PubMed |
| Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. | PLoS One | 2023 | 37656760 | PubTator, text mining | PubMed |
| Therapeutic targets in the brain for overactive bladder: A focus on angiotensin II type 1 receptor. | J Pharmacol Sci | 2023 | 37640471 | PubTator, text mining | PubMed |
| Modern and Non-Invasive Methods of Fat Removal. | Medicina (Kaunas) | 2023 | 37629668 | PubTator, text mining | PubMed |
| New Therapeutics for Heart Failure: Focusing on cGMP Signaling. | Int J Mol Sci | 2023 | 37629047 | PubTator, text mining | PubMed |
| Effects of the Trp64Arg Polymorphism in the ADRB3 Gene on Body Composition, Cardiorespiratory Fitness, and Physical Activity in Healthy Adults. | Genes (Basel) | 2023 | 37628593 | PubTator, text mining | PubMed |
| Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work. | J Cardiovasc Dev Dis | 2023 | 37623340 | PubTator, text mining | PubMed |
| Genetic Basis, New Diagnostic Approaches, and Updated Therapeutic Strategies of the Syndromic Aortic Diseases: Marfan, Loeys-Dietz, and Vascular Ehlers-Danlos Syndrome. | Int J Environ Res Public Health | 2023 | 37623198 | PubTator, text mining | PubMed |
| HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance. | J Clin Invest | 2023 | 37607030 | PubTator, text mining | PubMed |
| Defining Mitochondrial Cristae Morphology Changes Induced by Aging in Brown Adipose Tissue. | bioRxiv | 2023 | 37577723 | PubTator, text mining | PubMed |
| Fetal Oxygenation from the 23rd to the 36th Week of Gestation Evaluated through the Umbilical Cord Blood Gas Analysis. | Int J Mol Sci | 2023 | 37569862 | PubTator, text mining | PubMed |
| Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet? | Int J Mol Sci | 2023 | 37569855 | PubTator, text mining | PubMed |
| Structural basis of agonist specificity of α1A-adrenergic receptor. | Nat Commun | 2023 | 37563160 | PubTator, text mining | PubMed |
| Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling. | Clinics (Sao Paulo) | 2023 | 37557005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=14